Trial Profile
Optimalisation of the response to influenza virus vaccination in breast cancer and colorectal cancer patients immunocompromised due to chemotherapy.
Status:
Planning
Phase of Trial:
Phase IV
Latest Information Update: 14 Apr 2015
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccines (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Acronyms OFLUVAC
- 27 Apr 2011 New trial record